New York Life Investment Management »

Cidara Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 16k 220.89

More positions owned by New York Life Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
New York Life Invts Active E Nyli Mackay Core (CPLB)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
New York Life Investments Et Candriam Us Lrg (IQSU)
Meta Platforms Cl A (META)
New York Life Investments Et Candriam Us Mid (IQSM)
Tesla Motors (TSLA)
Vanguard World Mega Cap Index (MGC)
New York Life Investments Et Nyli Candriam In (IQSI)
Vanguard Scottsdale Fds Short Term Treas (VGSH)

View all positions for New York Life Investment Management

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics